Recently diagnosed with HIV? Click here

SCULPTRA Update: PBS-subsidised lipo treatment a step closer

Positive Living article • Adrian Ogier • 5 June 2009
Treating HIV

People with severe facial lipoatrophy caused by HIV treatments are closer to being able to access subsidised treatment with poly-lactic acid under the Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS).

A resubmission in March by sanofi-aventis, the company who manufactures the product under the name Sculptra, resulted in a positive recommendation by the Pharmaceutical Benefits Advisory Committee (PBAC) to list the facial filler.

‘This is only one step in the process,’ advises John Daye, NAPWHA’s treatments spokesperson. ‘Costing and referral arrangements are yet to be decided. But we are
hopeful Sculptra will become listed this year.’

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

This article was first published in the June 2009 issue of Positive Living — more than four years ago.

While the content of this was checked for accuracy at the time of publication, NAPWHA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWHA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.